1. Allegra JC (1983) Methotrexate and 5-fluorouracil following tamoxifen and premarin in advanced brest cancer. Semin Oncol 10, [Suppl 2]: 23–28
2. Beex LVAM, Rose C, Sylvester R, Rotmensz N (1987) Continuous tamoxifen versus intermittent tamoxifen versus alternating tamoxifen and medroxyprogesterone acetate (MPA). First line endocrine therapy for post-menopausal patients with advanced breast cancer, a phase III study (trial 10863). 4th EORTC breast cancer working conference, London, June 30-July 3, 1987, abstract no 1. 14
3. Bonadonna G, Valagussa P (1981) Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304: 10–15
4. Bruchowsky N, Rennie P, Van Doom E, Noble R (1978) Pathological growth of androgen sensitive tissue resulting from latent actions of steroid hormones. J Toxicol Environ Health 4: 391–408
5. Bruno M, Roldan E, Diaz B (1983) Sequential vs. simultanous administration of tamoxifen and medroxyprogesterone acetate in advanced breast cancer. J Steroid Biochem 19: 87 S, abstract 261